Arax Advisory Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Arax Advisory Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1K	Buy	+8	New	+$895	﹤0.01%	729

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Arax Advisory Partners's PRAH Position: Q4 2020 in Review

Arax Advisory Partners opened a new position in PRA Health Sciences, Inc. (PRAH) in Q4 2020: 8 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #729 among its holdings.

289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

Arax Advisory Partners held 8 shares of PRA Health Sciences, Inc. worth $1K as of Q4 2020.
PRA Health Sciences, Inc. was a new Arax Advisory Partners position in Q4 2020.
PRA Health Sciences, Inc. made up ﹤0.01% of Arax Advisory Partners's portfolio in Q4 2020, its #729 holding.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Arax Advisory Partners's 13F filing for Q4 2020, filed 3 Feb 2021.